Literature DB >> 27617662

Ipilimumab plus nivolumab for advanced melanoma.

Jessica C Hassel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27617662     DOI： 10.1016/S1470-2045(16)30409-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma.

Authors:  Qi Liu; Hongda Zhu; Yun Liu; Sara Musetti; Leaf Huang
Journal:  Cancer Immunol Immunother       Date:  2017-11-01       Impact factor: 6.968

2.  Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.

Authors:  Nathalie Rouas-Freiss; Joel LeMaoult; Jérôme Verine; Diana Tronik-Le Roux; Stéphane Culine; Christophe Hennequin; François Desgrandchamps; Edgardo D Carosella
Journal:  Oncoimmunology       Date:  2017-07-05       Impact factor: 8.110

3.  Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

Authors:  Jong-Ho Cha; Wen-Hao Yang; Weiya Xia; Yongkun Wei; Li-Chuan Chan; Seung-Oe Lim; Chia-Wei Li; Taewan Kim; Shih-Shin Chang; Heng-Huan Lee; Jennifer L Hsu; Hung-Ling Wang; Chu-Wei Kuo; Wei-Chao Chang; Sirwan Hadad; Colin A Purdie; Aaron M McCoy; Shirong Cai; Yizheng Tu; Jennifer K Litton; Elizabeth A Mittendorf; Stacy L Moulder; William F Symmans; Alastair M Thompson; Helen Piwnica-Worms; Chung-Hsuan Chen; Kay-Hooi Khoo; Mien-Chie Hung
Journal:  Mol Cell       Date:  2018-08-16       Impact factor: 17.970

Review 4.  Immune Checkpoint in Glioblastoma: Promising and Challenging.

Authors:  Jing Huang; Fangkun Liu; Zhixiong Liu; Hui Tang; Haishan Wu; Qianni Gong; Jindong Chen
Journal:  Front Pharmacol       Date:  2017-05-09       Impact factor: 5.810

5.  The Dosage of the Derivative of Clostridium Ghonii (DCG) Spores Dictates Whether an IFNγ/IL-9 or a Strong IFNγ Response Is Elicited in TC-1 Tumour Bearing Mice.

Authors:  Guoying Ni; Yong Wang; David Good; Jianwei Yuan; Xuan Pan; Jou Wei; Xiaosong Liu; Ming Q Wei
Journal:  Biomed Res Int       Date:  2019-04-28       Impact factor: 3.411

6.  Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.

Authors:  Liangliang Meng; Xiaoxi He; Xiao Zhang; Xiaobo Zhang; Yingtian Wei; Bin Wu; Wei Li; Jing Li; Yueyong Xiao
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

7.  Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial.

Authors:  Jessica C Hassel; Christiane Bieber; Pia Grabbe; Kathrin M Gschwendtner; Imad Maatouk; Sophia B Strobel; Martin Salzmann; Julia Bossert; Wolfgang Eich; Beate Wild; Friedegund Meier
Journal:  Trials       Date:  2021-04-20       Impact factor: 2.279
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.